The aim of this study was to determine the impact of delivery device reducing drug wastage.
Read moreDevelopment and implementation of the optimum price submission strategy for a product in the EU.
Read moreTo determine if there is a difference between incremental cost-effectiveness ratios (ICERs) in oncol...
Read moreIn the current climate of tighter budgetary controls and greater price scrutiny, a uniform pricing s...
Read moreOver the last year, the European Commission (EC) has been consulting on multiple scenarios for HTA h...
Read moreThe development of gene therapies represents a new frontier of science, with the potential to help p...
Read moreSince 2004, opportunity cost has been reflected in NICE's appraisal process through the specificatio...
Read moreThis study investigates NICE evaluations of new cancer indications and legacy CDF indications (not p...
Read morePaul Craddy is proud to be presenting at the Global Pharmaceutical Regulatory Affairs Summit in Prag...
Read moreThe Association of British Pharmaceutical Industry has been refused a legal challenge to a cap on th...
Read more